Cargando…

Contemporary Management of Dyslipidemia

The treatment of dyslipidemia continues to be a dynamic and controversial topic. Even the most appropriate therapeutic range for lipid levels—including that of triglycerides and low-density lipoprotein cholesterol—remain actively debated. Furthermore, with ever-increasing options and available treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferraro, Richard A., Leucker, Thorsten, Martin, Seth S., Banach, Maciej, Jones, Steven R., Toth, Peter P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931779/ https://www.ncbi.nlm.nih.gov/pubmed/35303294 http://dx.doi.org/10.1007/s40265-022-01691-6

Ejemplares similares

RNA Silencing in the Management of Dyslipidemias
por: Henney, Neil C., et al.
Publicado: (2021)

Dyslipidemia in women: etiology and management
por: Phan, Binh An P, et al.
Publicado: (2014)

2023: The year in cardiovascular disease – the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?
por: Banach, Maciej, et al.
Publicado: (2023)

Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7
por: Quispe, Renato, et al.
Publicado: (2019)

Inflammation and cardiovascular disease: From mechanisms to therapeutics
por: Alfaddagh, Abdulhamied, et al.
Publicado: (2020)

Modern prevalence of the Fredrickson-Levy-Lees dyslipidemias: findings from the Very Large Database of Lipids and National Health and Nutrition Examination Survey
por: Sathiyakumar, Vasanth, et al.
Publicado: (2019)

Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia
por: Sosnowska, Bożena, et al.
Publicado: (2022)

Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022)
por: Banach, Maciej, et al.
Publicado: (2022)

Contemporary Management and Attainment of Cholesterol Targets for Patients with Dyslipidemia in China
por: Gao, Fei, et al.
Publicado: (2013)

Malignancy-Associated Dyslipidemia
por: Bielecka-Dąbrowa, Agata, et al.
Publicado: (2011)

Evolocumab, a PCSK9‐Monoclonal Antibody, Rapidly Reverses Coronary Artery Endothelial Dysfunction in People Living With HIV and People With Dyslipidemia
por: Leucker, Thorsten M., et al.
Publicado: (2020)

Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?
por: Cicero, Arrigo F. G., et al.
Publicado: (2021)

Endothelial dysfunction as a nexus for endothelial cell-cardiomyocyte miscommunication
por: Leucker, Thorsten M., et al.
Publicado: (2014)

Plasma Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) in the Acute Respiratory Distress Syndrome
por: Metkus, Thomas S., et al.
Publicado: (2022)

A Contemporary Overview of PPARα/γ Dual Agonists for the Management of Diabetic Dyslipidemia
por: Balakumar, Pitchai, et al.
Publicado: (2019)

Management of dyslipidemia in children
por: Kalra, Sanjay, et al.
Publicado: (2009)

Dyslipidemia Management in Patients with Coronary Artery Disease. Data from the POLASPIRE Survey
por: Jankowski, Piotr, et al.
Publicado: (2021)

Novel Presentation of Homozygous Familial Hypercholesterolemia With Homozygous Variants in Both LDLR and APOB Genes
por: Derenbecker, Robert, et al.
Publicado: (2019)

Atherosclerosis in Fabry Disease—A Contemporary Review
por: Roy, Ashwin, et al.
Publicado: (2021)

Global Trends in the Epidemiology and Management of Dyslipidemia
por: Liu, Tianxiao, et al.
Publicado: (2022)

Screening and Management of Dyslipidemia in Children and Adolescents
por: Schefelker, Juliette M., et al.
Publicado: (2022)

Efficacy and safety of rosuvastatin in the management of dyslipidemia
por: Rubba, Paolo, et al.
Publicado: (2009)

Contemporary optimized practice in the management of pulmonary sarcoidosis
por: Aryal, Shambhu, et al.
Publicado: (2019)

Contemporary management of high-grade gliomas
por: Sim, Hao-Wen, et al.
Publicado: (2017)

Contemporary management of ejaculatory dysfunction
por: Gray, Marisa, et al.
Publicado: (2018)

Management of Statin Intolerance in 2018: Still More Questions Than Answers
por: Toth, Peter P., et al.
Publicado: (2018)

Contemporary Management of Prostate Cancer
por: Cotter, Katherine, et al.
Publicado: (2016)

Comparison of Current International Guidelines for the Management of Dyslipidemia
por: Aygun, Sevda, et al.
Publicado: (2022)

Overview of guidelines for the management of dyslipidemia: EU perspectives
por: Giner-Galvañ, Vicente, et al.
Publicado: (2016)

Contemporary management of cancer of the oral cavity
por: Genden, Eric M., et al.
Publicado: (2010)

Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism
por: Liu, Huixing, et al.
Publicado: (2022)

Osteoid osteoma: Contemporary management
por: Noordin, Shahryar, et al.
Publicado: (2018)

Contemporary Features and Management of Endocarditis
por: Comeaux, Shelby, et al.
Publicado: (2023)

Contemporary role of radiotherapy in the management of penile cancer
por: Korzeniowski, Martin Arthur, et al.
Publicado: (2017)

Atherogenic dyslipidemia
por: Manjunath, C. N., et al.
Publicado: (2013)

Diabetes Dyslipidemia
por: Schofield, Jonathan D., et al.
Publicado: (2016)

The pivotal role of cholesterol absorption inhibitors in the management of dyslipidemia
por: Al-Shaer, Moutasim H, et al.
Publicado: (2004)

Managing dyslipidemia in HIV/AIDS patients: challenges and solutions
por: Husain, Nazik Elmalaika OS, et al.
Publicado: (2014)

Dyslipidemia in patients with chronic kidney disease: etiology and management
por: Mikolasevic, Ivana, et al.
Publicado: (2017)

A Jordanian Multidisciplinary Consensus Statement on the Management of Dyslipidemia
por: Al Mousa, Eyas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_806ohaps4pnbcpphj64elial0f